OMC
BCAB icon

Oasis Management Company’s BioAtla BCAB Stock Holding History

Oasis Management Company’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,797
Closed -$2.39M – 81
2022
Q4 		$2.39M Hold
5,797
– – 0.48% 34
2022
Q3 		$2.23M Hold
5,797
– – 0.37% 36
2022
Q2 		$826K Buy
+5,797
New +$923K 0.15% 61

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Oasis Management Company's BCAB Position: Q1 2023 in Review

Oasis Management Company sold out of BioAtla (BCAB) in Q1 2023, closing a stake of 5,797 shares — an estimated $2.39M sold.

Oasis Management Company first reported a position in BCAB in Q2 2022 and held it in 3 quarters. The position peaked at $2.39M in Q4 2022. 79 funds tracked by Wall St. Rank hold BCAB as of Q1 2023.

  • Oasis Management Company reported no remaining BioAtla position as of Q1 2023 after selling out during the quarter.
  • Oasis Management Company sold 5,797 BioAtla shares in Q1 2023, an estimated $2.39M.
  • Oasis Management Company first reported a position in BioAtla in Q2 2022 and held it in 3 quarters.
  • Oasis Management Company's BioAtla position peaked at $2.39M in Q4 2022.
  • 79 funds tracked by Wall St. Rank held BioAtla as of Q1 2023.

Based on Oasis Management Company's 13F filing for Q1 2023, filed 15 May 2023.